IL-22 has also been shown to induce smoking-dependent airway remodeling and emphysema-like alveolar enlargement in chronic obstructive pulmonary disease [117], as well as the recruitment, activation, and proliferation of mononuclear cells, contributing to alveolitis and granuloma formation in sarcoidosis [118]. Here, IL22 is linked to hypersensitivity pneumonitis.